InvestorsHub Logo
Followers 30
Posts 1494
Boards Moderated 1
Alias Born 10/15/2014

Re: None

Sunday, 08/15/2021 7:53:09 PM

Sunday, August 15, 2021 7:53:09 PM

Post# of 42511
Lenzilumab should have received an EUA two Junes ago when we had estimated it to be. So the FDA goes to our CEO immediately as the crisis starts. They come all excited. They direct Humanigen to go in the direction of getting an EUA for the most sever patients. Even though Lenzilumab has results that blow Remdesivir and everyone else out of the water for less severe patients. The thinking by Humanigen was probably, "Hey, lets get this EUA for severe patients out of the way then focus on test for all levels." But no. The FDA and all the rest drag the trial as much as they can. Now drag the approval. They are probably hoping that with illegal shorting and all that they can pressure Humanigen to be bought up by a Big Pharma company that will only close the lights on the cure so that people think that the mRNA treatment that creates deadly proteins that can become airborne or transferred to others through touch is the only option. I bet they were afraid that if Lenzilumab was to be tested more on the less severe patients, maybe even test other ways to deliver it to non severe patients to where it could be prescribed, that just too much would have been learned on how to stop this virus.